CVS: Rerating – Downgrade From Strong Buy To Hold (NYSE: CVS)

Boston Area Continues Covid-19 Testing At Sites Around City

Maddie Meyer


In late July 2023, I released a post with a strong buy score on CVS Health ( NYSE: CVS), which you can gain access to here At the time, CVS was securely in the market’s “dog house”: the stock was 52% off its

Like this post? Please share to your friends:
Leave a Reply

;-) :| :x :twisted: :smile: :shock: :sad: :roll: :razz: :oops: :o :mrgreen: :lol: :idea: :grin: :evil: :cry: :cool: :arrow: :???: :?: :!: